Nonstandard Peptide Binding Revealed by Crystal Structures of HLA-B*5101 Complexed with HIV Immunodominant Epitopes1
暂无分享,去创建一个
D I Stuart | E Y Jones | E. Jones | M. Takiguchi | K. Maenaka | K Maenaka | M Takiguchi | David I. Stuart | T Maenaka | H Tomiyama | H. Tomiyama | T. Maenaka
[1] K. Tadokoro,et al. Sequence-based association analysis of HLA class I and II alleles in Japanese supports conservation of common haplotypes , 1997, Immunogenetics.
[2] Partho Ghosh,et al. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2 , 1996, Nature.
[3] J. Strominger,et al. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[4] K. Sharp,et al. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.
[5] O. Mandelboim,et al. The binding site of NK receptors on HLA-C molecules. , 1997, Immunity.
[6] A. Townsend,et al. Antigen recognition by class I-restricted T lymphocytes. , 1989, Annual review of immunology.
[7] P. Parham,et al. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor , 1995, The Journal of experimental medicine.
[8] Eric O Long,et al. A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705 , 1996, The Journal of experimental medicine.
[9] J. Strominger,et al. Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[10] Z. Otwinowski,et al. Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[11] B M Baker,et al. Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. , 1999, Immunity.
[12] Eric O Long,et al. Binding of a soluble p70 killer cell inhibitory receptor to HLA‐B*5101: Requirement for all three p70 immunoglobulin domains , 1997, European journal of immunology.
[13] Katsuaki Tanaka,et al. Binding of 8-mer to 11-mer peptides carrying the anchor residues to slow assembling HLA class I molecules (HLA-B*5101) , 1997, Immunogenetics.
[14] S. Rowland-Jones,et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women , 1995, Nature Medicine.
[15] E A Merritt,et al. Raster3D Version 2.0. A program for photorealistic molecular graphics. , 1994, Acta crystallographica. Section D, Biological crystallography.
[16] D. Stuart,et al. Production and crystallization of MHC class I B allele single peptide complexes , 1996, FEBS letters.
[17] V. Gnau,et al. Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behćet's disease. , 1995, International immunology.
[18] D. Stuart,et al. Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I. , 1999, Structure.
[19] L R Pease,et al. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. , 1998, Science.
[20] D I Stuart,et al. An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. , 1996, Immunity.
[21] K. Harlos. Micro-bridges for sitting-drop crystallizations , 1992 .
[22] L. Lanier. NK cell receptors. , 1998, Annual review of immunology.
[23] R M Esnouf,et al. An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. , 1997, Journal of molecular graphics & modelling.
[24] Kiyoshi Miwa,et al. Residue 116 determines the C-terminal anchor residue of HLA-B*3501 and -B*5101 binding peptides but does not explain the general affinity difference , 1998, Immunogenetics.
[25] Eric O Long,et al. Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors , 1997, Nature.
[26] E Y Jones,et al. MHC superfamily structure and the immune system. , 1999, Current opinion in structural biology.
[27] B. Walker,et al. T lymphocyte responses in HIV-1 infection: implications for vaccine development. , 1999, Current opinion in immunology.
[28] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.
[29] D I Stuart,et al. Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. , 1996, Immunity.
[30] W. Saenger,et al. Decamer-like conformation of a nona-peptide bound to HLA-B*3501 due to non-standard positioning of the C terminus. , 1998, Journal of molecular biology.
[31] K. Miwa,et al. The role of the amino acids associated with the HLA-Bw4/Bw6 epitope in peptide binding to HLA-B5, B35 CREG molecules , 1999, Immunogenetics.
[32] H. Inoko,et al. Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's disease. , 1999, Arthritis and rheumatism.
[33] Eric O Long,et al. Peptide specificity in the recognition of MHC class I by natural killer cell clones , 1995, Science.
[34] D. Stuart,et al. Antagonist HIV-1 Gag Peptides Induce Structural Changes in HLA B8 , 1996, The Journal of experimental medicine.
[35] S. Rowland-Jones,et al. Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity peptide binding to B*2703. , 1994, Immunity.
[36] P Parham,et al. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. , 1997, Journal of immunology.
[37] C. Schönbach,et al. Fine tuning of peptide binding to HLA-B*3501 molecules by nonanchor residues. , 1995, Journal of immunology.
[38] Don C. Wiley,et al. Structure of Human Histocompatibility Leukocyte Antigen (Hla)-Cw4, a Ligand for the Kir2d Natural Killer Cell Inhibitory Receptor , 1999, The Journal of experimental medicine.
[39] Kiyoshi Miwa,et al. Predominant role of N-terminal residue of nonamer peptides in their binding to HLA-B* 5101 molecules , 1997, Immunogenetics.
[40] D. Madden. The three-dimensional structure of peptide-MHC complexes. , 1995, Annual review of immunology.
[41] É. Oksenhendler,et al. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. , 1994, The Journal of clinical investigation.
[42] D. Wiley,et al. Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. , 1998, Immunity.
[43] S. Oka,et al. Identification of multiple HIV-1 CTL epitopes presented by HLA-B*5101 molecules. , 1999, Human immunology.
[44] D. Wiley,et al. The three-dimensional structure of a class I major histocompatibility complex molecule missing the alpha 3 domain of the heavy chain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[45] J. Zou,et al. Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.
[46] D. Wiley,et al. The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2 , 1993, Cell.